Phase II study of anlotinib in combination with oxaliplatin and capecitabine for patients with RAS/BRAF wild-type metastatic colorectal adenocarcinoma as the first-line therapy

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1741-7015
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Phase II study of anlotinib in combination with oxaliplatin and capecitabine for patients with RAS/BRAF wild-type metastatic colorectal adenocarcinoma as the first-line therapy ; volume:20 ; number:1 ; day:6 ; month:5 ; year:2022 ; pages:1-10 ; date:12.2022
BMC medicine ; 20, Heft 1 (6.5.2022), 1-10, 12.2022

Creator
Liu, Yue
Xiao, Qian
He, Jinjie
Hu, Hanguang
Du, Jinlin
Zhu, Yuping
Chen, Jiaqi
Liu, Zhuo
Wang, Jianping
Sun, Lifeng
Xu, Dong
Li, Jun
Liao, Xiujun
Wang, Jianwei
Cai, Yibo
Cai, Cheng
Jin, Zhekang
Wang, Liuhong
Yuan, Ying
Ding, Kefeng
Contributor
SpringerLink (Online service)

DOI
10.1186/s12916-022-02357-6
URN
urn:nbn:de:101:1-2022062619313714707900
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:30 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

  • Liu, Yue
  • Xiao, Qian
  • He, Jinjie
  • Hu, Hanguang
  • Du, Jinlin
  • Zhu, Yuping
  • Chen, Jiaqi
  • Liu, Zhuo
  • Wang, Jianping
  • Sun, Lifeng
  • Xu, Dong
  • Li, Jun
  • Liao, Xiujun
  • Wang, Jianwei
  • Cai, Yibo
  • Cai, Cheng
  • Jin, Zhekang
  • Wang, Liuhong
  • Yuan, Ying
  • Ding, Kefeng
  • SpringerLink (Online service)

Other Objects (12)